All Stories

  1. Predictive models for acute oral systemic toxicity: A workshop to bridge the gap from research to regulation
  2. Evaluation of androgen assay results using a curated Hershberger database
  3. International regulatory requirements for skin sensitization testing
  4. Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies
  5. In vitro to in vivo extrapolation for high throughput prioritization and decision making
  6. Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database
  7. Non-animal methods to predict skin sensitization (II): an assessment of defined approaches
  8. Highlight report: ‘Big data in the 3R’s: outlook and recommendations’, a roundtable summary
  9. Integrated decision strategies for skin sensitization hazard
  10. Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods
  11. Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences
  12. Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences
  13. Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform
  14. An Integrated Chemical Environment to Support 21st-Century Toxicology
  15. Pred-Skin: A Fast and Reliable Web Application to Assess Skin Sensitization Effect of Chemicals
  16. Prediction of skin sensitization potency using machine learning approaches
  17. Machine Learning Approaches to Predict PhysChem Properties of Environmental Chemicals
  18. Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity
  19. Development and Validation of a Computational Model for Androgen Receptor Activity
  20. Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells
  21. Analysis of the Effects of Cell Stress and Cytotoxicity onIn VitroAssay Activity Across a Diverse Chemical and Assay Space
  22. Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations
  23. Multivariate models for prediction of human skin sensitization hazard
  24. Editor's Highlight: Analysis of the Effects of Cell Stress and Cytotoxicity onIn VitroAssay Activity Across a Diverse Chemical and Assay Space
  25. Integration of Life-Stage Physiologically Based Pharmacokinetic Models with Adverse Outcome Pathways and Environmental Exposure Models to Screen for Environmental Hazards
  26. Adverse outcome pathways: From research to regulation scientific workshop report
  27. Integrated decision strategies for skin sensitization hazard
  28. QSAR models of human data can enrich or replace LLNA testing for human skin sensitization
  29. Toward Good Read-Across Practice (GRAP) guidance
  30. Supporting read-across using biological data
  31. A Curated Database of Rodent Uterotrophic Bioactivity
  32. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model
  33. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
  34. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis
  35. Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization
  36. Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds
  37. A Vision of Toxicity Testing in the 21st Century
  38. Application of Reverse Dosimetry to Compare In Vitro and In Vivo Estrogen Receptor Activity
  39. Immediate and long-term consequences of vascular toxicity during zebrafish development
  40. Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms
  41. Integrated Testing Strategies (ITS) for safety assessment
  42. Open source software implementation of an integrated testing strategy for skin sensitization potency based on a Bayesian network
  43. Dosimetric Anchoring of In Vivo and In Vitro Studies for Perfluorooctanoate and Perfluorooctanesulfonate
  44. A C. elegans Screening Platform for the Rapid Assessment of Chemical Disruption of Germline Function
  45. A Computational Model Predicting Disruption of Blood Vessel Development
  46. Predictive Models and Computational Toxicology
  47. In Vitro Perturbations of Targets in Cancer Hallmark Processes Predict Rodent Chemical Carcinogenesis
  48. Incorporating Biological, Chemical, and Toxicological Knowledge Into Predictive Models of Toxicity
  49. Computational toxicology and in silico modeling of embryogenesis
  50. Update on EPA’s ToxCast Program: Providing High Throughput Decision Support Tools for Chemical Risk Management
  51. Zebrafish developmental screening of the ToxCast™ Phase I chemical library
  52. Predictive modeling and computational toxicology
  53. Disruption of embryonic vascular development in predictive toxicology
  54. Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics
  55. Predictive Models of Prenatal Developmental Toxicity from ToxCast High-Throughput Screening Data
  56. Environmental Impact on Vascular Development Predicted by High-Throughput Screening
  57. Evaluation of 309 Environmental Chemicals Using a Mouse Embryonic Stem Cell Adherent Cell Differentiation and Cytotoxicity Assay
  58. Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets
  59. Dynamic myogenic autoregulation in the rat kidney: a whole-organ model